✦ LIBER ✦

Current status of interferon alpha in the treatment of chronic hepatitis B

✍ Scribed by Braken, J. B. ;Koopmans, P. P. ;Van Munster, I. P. ;Gribnau, F. W. J.

Publisher: Springer
Year: 1992
Tongue: Dutch
Weight: 764 KB
Volume: 14
Category: Article
ISSN: 1573-739X
DOI: 10.1007/bf01962533

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with human gamma interferon of

Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon

✍ Shinichi Kakumu; Tetsuya Ishikawa; Masashi Mizokanii; Etsuro Orido; Kentaro Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract A pilot study was designed to determine the tolerance and effectiveness of natural or recombinant gamma interferon in patients with chronic hepatitis B. Sixteen patients received 0.5 to 3.0 million units (MU) per day of gamma interferon (IFN‐γ) for 7 days. Nineteen chronic hepatitis B p

Recombinant leukocyte interferon treatme

Recombinant leukocyte interferon treatment of chronic hepatitis B

✍ Geoffrey Dusheiko; Adrian Dibisceglie; Sheila Bowyer; Evelyn Sachs; Marian Ritch 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

We have investigated the efficacy of a relatively prolonged course of recombinant leukocyte interferon treatment in 14 chronic HBsAg-, HBeAg-, hepatitis B virus DNA-and DNA polymerasepositive carriers. a-Interferon was administered for 9 weeks. Six of 14 treated carriers have a sustained loss of HBe

Long-term follow-up of alpha-interferon

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

✍ Monika van Zonneveld; Pieter Honkoop; Bettina E. Hansen; Hubertus G.M. Niesters; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Treatment of chronic hepatitis E in live

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b

✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren

Treatment of chronic hepatitis C by cont

Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha

✍ Dr. Vicente Carreño; Luis Tapia; Jean-Charles Ryff; Juan Antonio Quiroga; Inmacu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

## Abstract The effectiveness of a daily continuous infusion of interferon‐alpha was evaluated in 12 patients (10 males, 2 females; mean age of 33 years, range 19–62) with biopsy‐proven chronic active hepatitis C. Nine million units (MU) of recombinant interferon‐alpha 2A (rIFN‐α 2A) were administe

Neurovisual impairment: A frequent compl

Neurovisual impairment: A frequent complication of alpha-interferon treatment in chronic viral hepatitis

✍ Emanuel K. Manesis; Michael Moschos; Dimitrios Brouzas; John Kotsiras; Constanti 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Following our earlier observation of clinically evident optic tract neuropathy in patients receiving low-dose interferon (IFN) therapy, we prospectively evaluated 53 consecutive patients treated for chronic hepatitis B or C with a median dose of 3 MU of IFN-a 2b thrice weekly. Measurements included